Qing Hai Zhao
Corporate Officer/Principal bij ADAGENE INC.
Actieve functies van Qing Hai Zhao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ADAGENE INC. | Corporate Officer/Principal | 01-10-2020 | - |
Loopbaan van Qing Hai Zhao
Eerdere bekende functies van Qing Hai Zhao
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FORTY SEVEN, INC. | Corporate Officer/Principal | 01-01-2017 | 01-10-2020 |
ANAPTYSBIO, INC. | Corporate Officer/Principal | 01-01-2016 | 01-01-2017 |
NGM BIOPHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-01-2014 | 01-01-2016 |
Corporate Officer/Principal | 01-01-2014 | 01-01-2016 |
Opleiding van Qing Hai Zhao
East China University of Science & Technology | Undergraduate Degree |
University of Uppsala | Doctorate Degree |
Zhongshan Hospital Fudan University | Graduate Degree |
Statistieken
Internationaal
China | 4 |
Verenigde Staten | 4 |
Zweden | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ADAGENE INC. | Health Technology |
ANAPTYSBIO, INC. | Health Technology |
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
- Beurs
- Insiders
- Qing Hai Zhao
- Ervaring